loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Bromhexine Hydrochloride

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Bromhexine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 50Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mexico raises cough medicine objection to Sanofi-Boehringer deal
    Mexico raises cough medicine objection to Sanofi-Boehringer deal

    19 Dec 2016

    // Michael O\'Boyle REUTERS

    http://uk.reuters.com/article/mexico-sanofi-idUKL1N1EE0YZ?rpc=401&

    Michael O\'Boyle REUTERS
    19 Dec 2016
    Share Share
    EC Confirms Use of Ambroxol and Bromhexine APIs
    EC Confirms Use of Ambroxol and Bromhexine APIs

    26 Jan 2016

    // DCAT CONNECT

    http://connect.dcat.org/blogs/pharma-news/2016/01/26/ec-confirms-use-of#.VqhfhJp97IU

    DCAT CONNECT
    26 Jan 2016
    Share Share
    Sanofi Seeks $25 Billion Deal in Asset Talks With Boehringer
    Sanofi Seeks $25 Billion Deal in Asset Talks With Boehringer

    15 Dec 2015

    // Albertina Torsoli BLOOMBERG

    http://www.bloomberg.com/news/articles/2015-12-15/sanofi-in-negotiations-to-swap-assets-with-boehringer-ingelheim

    Albertina Torsoli BLOOMBERG
    15 Dec 2015
    Share Share
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    02 May 2015

    // Eric Palmer FIERCE PHARMA MFG

    http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

    Eric Palmer FIERCE PHARMA MFG
    02 May 2015
    Share Share
    Ambroxol and Bromhexine Expectorants: Safety Information to Be Updated
    Ambroxol and Bromhexine Expectorants: Safety Information to Be Updated

    28 Feb 2015

    // EMA

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/02/news_detail_002276.jsp&mid=WC0b01ac058004d5c1

    EMA
    28 Feb 2015
    Share Share